Results 301 to 310 of about 384,141 (378)
Extraction of pH-Dependent DNA-Binding Anti-Tumoral Peptides from <i>Saccharomyces cerevisiae</i>. [PDF]
Ragonese F, Mancinelli L.
europepmc +1 more source
ABSTRACT Aim To examine the significance of portal vein tumor thrombus (PVTT) as a prognostic factor for patients with pancreatic ductal adenocarcinoma (PDAC) treated with chemoradiotherapy (CRT) followed by surgery. Methods The study retrospectively examined 313 patients with borderline resectable (BR) or locally advanced (LA) PDAC who underwent CRT ...
Aoi Hayasaki +9 more
wiley +1 more source
Extramedullary Disease—Achilles Heel in Myeloma?
ABSTRACT Despite advances in therapy, extramedullary disease (EMD) remains an aggressive form of multiple myeloma associated with poor outcomes. Patients with true EMD, in which plasmacytomas have become completely independent of bone, have a particularly poor prognosis. The pathogenesis of EMD is driven by complex mechanisms involving loss of adhesion
Shaji Kumar +7 more
wiley +1 more source
Identification of novel therapeutic inhibitors against E6 and E7 oncogenes of HPV-16 associated with cervical cancer. [PDF]
Younas S +6 more
europepmc +1 more source
Insights into organelle forming RNAs: Diversity, functions and future perspectives
RNA molecules play crucial roles in the formation and maintenance of cellular structures and organelles. These ‘organelle formation RNAs’ include ribosomal RNAs, paraspeckle‐forming RNAs, nuclear speckle‐forming RNAs, nucleolus‐forming RNAs, and cytoskeleton‐forming RNA.
Meng Gong, Xiangting Wang, Xiaolin Liang
wiley +1 more source
Super enhancers as key drivers of gene regulatory networks in normal and malignant hematopoiesis. [PDF]
Cheng Y +7 more
europepmc +1 more source
Characterization of inflammatory pseudotumors in a large animal model of liver cancer
CT images in arterial and portal venous phases of liver lesions in Oncopig. Abstract Background The development of relevant and robust large animal models of hepatocellular carcinoma is needed to test new therapeutic strategies for this disease. Transgenic approaches hold promise in addressing this complex problem. One such model, the Oncopig, has been
Erik N. K. Cressman +4 more
wiley +1 more source
Aberrant expression of MAPK1 and MCTS1 in chronic myeloid leukemia (CML). [PDF]
Kortendick L, Meyer C, Nagel S.
europepmc +1 more source

